Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment
Clinical trial NCT00083967 · TERMINATED
Trial details
- NCT number
- NCT00083967
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2006-04-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.